Escalating Doses of Torisel in Combination With Three Chemotherapies Regimens: R-CHOP, R-FC or R-DHA for Patients With Relapsed/Refractory Mantle Cell Lymphoma (MCL).

NCT01389427 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Mantle Cell Lymphoma Refractory

Interventions

DRUG: Torisel dose 15 mg and R-CHOP
DRUG: Torisel dose 15 mg and R-FC
DRUG: Torisel dose 15 mg and R-DHA
DRUG: Torisel dose 25 mg and R-CHOP
DRUG: Torisel dose 50 mg and R-CHOP
DRUG: Torisel dose 75 mg and R-CHOP
DRUG: Torisel dose 25 mg and R-FC
DRUG: Torisel dose 50 mg and R-FC
DRUG: Torisel dose 75 mg and R-FC
DRUG: Torisel dose 25 mg and R-DHA
DRUG: Torisel dose 50 mg and R-DHA
DRUG: Torisel 75 mg and R-DHA

Sponsor

The Lymphoma Academic Research Organisation

Collaborators

[object Object]